<DOC>
	<DOCNO>NCT01575340</DOCNO>
	<brief_summary>The purpose study evaluate whether supplementation 2g/day encapsulate fish oil modifies inflammatory marker individual colorectal cancer chemotherapy</brief_summary>
	<brief_title>Study Assess Effect Consumption Fish Oil Encapsulated Inflammatory Markers Colorectal Cancer</brief_title>
	<detailed_description>The study recruit patient newly diagnose colorectal cancer yet undergone chemotherapy treatment . Individuals meet inclusion criterion randomize mean computer program two study group : 1 ) supplement Experimental : receive 2g/day supplementation encapsulate fish oil 9 week . 2 ) No intervention - control : receive supplementation fish oil placebo . Will assess effect supplementation standard profile cytokine production , nutritional status , proportion incorporation fatty acid blood cell ( mononuclear red blood cell ) . Blood sample collect start first chemotherapy nine week later . Supplementation experimental group also start first day chemotherapy .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<criteria>Age â‰¥ 19 year Histopathological diagnosis colorectal cancer Beginning chemotherapy target institution Agree participate study [ signature IC ] Age &lt; 19 year Being palliative care Inability oral intake Allergic fish fish product Owning hyperlipidemia require drug treatment Consumption prior study fish oil supplement contain omega3 PUFA Being medical treatment nonsteroidal antiinflammatory Have kind infection</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>inflammatory marker</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>cytokine</keyword>
	<keyword>fish oil</keyword>
</DOC>